Coasting', a method which consists of stopping exogenous gonadotrophins and postponing HCG administration until the patient's serum estradiol (E 2 ) level decreases, is often used to prevent ovarian hyperstimulation syndrome (OHSS). We conducted a systematic review to analyse whether there is suf®cient evidence to justify the general acceptance of coasting. The studies, which involved 493 patients in 12 studies, are very heterogeneous in the characteristics and number of patients in the ovulation stimulation schemes. The study designs, control groups, selection criteria for coasting and the OHSS classi®cations were variable. In most studies a threshold value of E 2 was used (often 3000 pg/ml) and/or the number of follicles were considered. The fertilization rates (36.7±71%) and the pregnancy rates (20±57%) were acceptable in terms of IVF results in comparison with those of other large IVF databanks. In 16% of the cycles, ascites was described and 2.5% of the patients required hospitalization. In conclusion, while coasting does not avoid totally the risk of OHSS, it decreases its incidence in high-risk patients. Many questions remain unanswered about how coasting should be managed, and we suggest that a randomized prospective multicentre study is required.
Introduction
Ovarian hyperstimulation syndrome (OHSS) is a potentially fatal iatrogenic complication of gonadotrophin administration used in IVF procedures (Mozes et al., 1965) . IVF is not a vital treatment and there is currently no speci®c treatment for OHSS. Therefore, it is imperative to avoid OHSS by using ef®cient prevention measures. In a survey conducted among gynaecologists specializing in fertility treatment,`coasting' appeared to be the most popular method used to prevent OHSS (Delvigne and Rozenberg, 2000) . This technique was ®rst described in overstimulated cycles by Rabinovici et al. and also used by Urman et al. (Rabinovici et al., 1987; Urman et al., 1992) ; it was ®rst applied in IVF cycles by Sher et al. in 1993 (Sher et al., 1993 . The method is based on the assumption that estradiol (E 2 ) levels achieved at the time of HCG administration are predictive of the risk of developing OHSS. When a patient considered to be at risk has a high E 2 level, exogenous gonadotrophins are stopped while GnRH agonists are maintained. The HCG administration is postponed until the patient's serum E 2 level decreases to a`safer zone', attesting to atresia of granulosa cells.
There are many advantages to using this technique. First, the cycle is not abandoned. Second, this technique allows the transfer of fresh embryos, in contrast to cryopreservation, another method that is used to avoid OHSS. Finally, no supplementary procedure or medical therapy is involved in coasting. It is therefore not surprising that about two-thirds of the physicians who choose to apply a preventive method advocated the use of coasting in our previous survey (Delvigne and Rozenberg, 2000) .
The aim of the study was to review, systematically, whether there is suf®cient evidence to justify the general acceptance of coasting.
Methods
A Medline search was carried out with the keywords`IVF' and coasting' for the years 1980±2001. Fifteen articles were found (Sher et al., 1993 (Sher et al., , 1995 Benadiva et al., 1997; Dhont et al., 1998; Feichtinger, 1998; Lee et al., 1998; Tortoriello et al., 1998; Egbase et al., 1999; Fluker et al., 1999; Waldenstro Èm et al., 1999; Human Reproduction Update, Vol.8, No.3 pp. 291±296, 2002 Ó European Society of Human Reproduction and Embryology Aboulghar et al., 2000; Dechaud et al., 2000; Egbase, 2000; Ohata et al., 2000; Al-Shawaf et al., 2001) , of which 14 presented results of series of patients. Three articles were eliminated, either because they were not really related to the topic (Feichtinger et al., 1998) or because they were repeated reports of the same patient population (Sher et al., 1993; Egbase, 2000) and we included therefore only the largest series of those patients in our analysis. We had ®rst decided to include only articles from randomized studies, but only one study (with a rather low number of subjects) appeared to be prospective and randomized (Egbase et al., 1999) . Therefore, we conducted a qualitative, critical review of the data of 12 articles. For this analysis we considered only as coasted patients those for whom gonadotrophins had been totally and de®nitely stopped.
We paid attention to the methodology that was used, the study design, the type of control groups and possible sources of bias. The following sources of heterogeneity were studied: the number of patients included and their selection criteria, and the`coasting action' that was undertaken.
Finally, we evaluated whether the conclusions that were drawn from these studies were supported by the data.
Patient selection criteria and design of the studies
In total, 493 patients were followed in 12 studies which evaluated coasting, but some studies involved as few as ®ve patients and the largest involved 120 patients (Table I) . Data about the patients' age were only available for 10 studies. The mean age varied between 29.9 and 37.3 years within the studies and the extremes were 23±42 years. Eight studies provided information about the aetiology of their patients' sterility. Out of 242 patients, 78 couples suffered from a male fertility problem, 82 from tubal damage, 40 from anovulation and polycystic ovarian syndrome (PCOS), 31 from idiopathic sterility and 23 from endometriosis. Thus, within the group of patients with a known aetiology,~13% presented PCOS, a well known risk factor of OHSS.
For four other studies, the causes of infertility were not provided per se, but Tortoriello et al. mentioned that they had twice as many PCOS cases in the group of coasted patients than in their control group (Tortoriello et al., 1998) , while in the study of Dhont et al. there was no difference in aetiology between control groups and the coasted patients (Dhont et al., 1998) . Finally, for two other studies, no information about aetiology was provided at all (Fluker et al., 1999; Aboulghar et al., 2000) .
Another source of heterogeneity between the studies is the type of stimulation scheme that was used. In most studies, a long-term scheme with GnRH analogue was used (Sher et al., 1995; Benadiva et al., 1997; Lee et al., 1998; Tortoriello et al., 1998; Egbase et al., 1999; Fluker et al., 1999; Waldenstro Èm et al., 1999; Aboulghar et al., 2000; Dechaud et al., 2000; Ohata et al., 2000; Al-Shawaf et al., 2001) . Only Dhont et al. used a short-term scheme with GnRH analogue (Dhont et al., 1998) . Ovarian stimulation occurred using either HMG only (Benadiva et al., 1997; Dhont et al., 1998; Tortoriello et al., 1998; Egbase et al., 1999; Fluker et al., 1999; Aboulghar et al., 2000; Dechaud et al., 2000; Ohata et al., 2000) , HMG in association with FSH (Sher et al., 1995) , 1997 (22) 34.5 T 3.6 E 2 b3000 Retrospective/cryopreserved patients Tortoriello et al., 1998 (44) 32.6 T 0.7 E 2 >3000 and ®ve or more follicles Retrospective/subgroup of coasted b16 mm and two follicles b19 mm versus two control groups Dhont et al., 1998 (120) NA E 2 >2500 and follicle number b20 Retrospective/historical cohort Lee et al., 1998 (20) NA E 2 >2777 and many immature follicles Retrospective/IVF patients of which less than three follicles >18 mm Fluker et al., 1999 (63) 32.2 T NA) E 2 rose rapidly and generally >3000 Descriptive/NA Waldenstrom et al., 1999 (65) 31.5 (23±39)`Very high E 2 ' and >25`large Descriptive/NA follicles' of which the three largest b17 mm Egbase et al., 1999 (15) 33.5 T 2.8 E 2 >6000 and >15 follicles/ovary and Prospective randomized early two or more >18 mm follicular aspiration Dechaud et al., 2000 (14) NA E 2 b5000 and/or >20 follicles of Descriptive/NA which three or more follicles b18 mm without abdominal pain Ohata et al., 2000 (5) 32 (25±37) b30% follicles b16 mm and severe Descriptive/NA OHSS in previous cycle Aboulghar et al., 2000 (24) 29.9 T 4.6 E 2 >3000 and >20 follicles with a Retrospective/historical group dominant follicle b16 mm Al-Shawaf et al., 2001 (50) 32.5 T 4.5 >20 follicles and 25% b15 mm,
Information about the daily dose was generally missing, except for in the studies of Lee (161 IU), Dhont (225 IU), Egbase (150 IU), Aboulghar (150±300 IU in relation to the patient's age) and Al-Shawaf (varying doses of 112.5±450 IU) (Dhont et al., 1998; Lee et al., 1998; Egbase et al., 1999; Aboulghar et al., 2000; Al-Shawaf et al., 2001) . Ovulation was induced in three studies by administering 5000 units of HCG (Waldenstro Èm et al., 1999; Dechaud et al., 2000; Ohata et al., 2000) , but more often, with 10 000 units (Sher et al., 1995; Dhont et al., 1998; Tortoriello et al., 1998; Egbase et al., 1999; Fluker et al., 1999; Aboulghar et al., 2000; Al-Shawaf et al., 2001) . In all studies published so far, progesterone supplementation was provided during the luteal phase, either i.m., vaginally or anally.
The selection criteria which determined the decision to use coasting were variable. Either a threshold value of E 2 was used, or the E 2 slope and/or the number of follicles seen by ultrasound were considered (Table I ). The threshold value of E 2 varied between 2500 pg/ml (pmol/l conversion factor 3671) and 6000 pg/ml with a majority of studies selecting 3000 pg/ml (Sher et al., 1995; Benadiva et al., 1997; Tortoriello et al., 1998; Fluker et al., 1999; Aboulghar et al., 2000) . In two studies, this value was not described. In addition to the E 2 level, some investigators also considered the number of follicles when deciding whether to coast. Seven authors chose to coast when 20±30 follicles were visualized, while eight authors also considered the proportion of the follicles having reached a mature size (15±19 mm) ( Table I) . The heterogeneity is even more exempli®ed by the fact that some authors used inverse criteria to decide to begin coasting [fewer than three follicles >18mm for Lee et al. (Lee et al., 1998) (Dechaud et al., 2000) .
Seven authors compared their results with control groups (Benadiva et al., 1997; Dhont et al., 1998; Lee et al., 1998; Tortoriello et al., 1998; Aboulghar et al., 2000; Ohata et al., 2000; Al-Shawaf et al., 2001) while four described only their coasted patients (Sher et al., 1995; Fluker et al., 1999; Waldenstro Èm et al., 1999; Dechaud et al., 2000) . Only Egbase conducted a prospective study and randomized patients at risk between two interventions: either coasting (n = 15) or early follicular aspiration (n = 15) (Egbase et al., 1999) .
Benadiva et al. used as a control group 26 patients in whom oocytes were retrieved when the patient reached an E 2 level of at least 4000 pg/ml, after which all embryos were cryopreserved and transferred during a later cycle (Benadiva et al., 1997). Tortoriello et al. proposed to 62 patients who reached a threshold level of E 2 of 3000 pg/ml, to choose between either coasting (n = 44) or immediate HCG administration (n = 18). Since the E 2 level in the coasted group was much higher than in the control group (4044 T 102 versus 3466 T 475 pg/ml), he subdivided the coasted patients into two groups: those who had reached E 2 levels of 3000±3999 pg/ml (n = 22), which were compared with the control noncoasted groups, and those who had reached E 2 levels >4000 pg/ ml, who were excluded from this comparison. He also used an additional control group of 22 women who had a normal response curve (Tortoriello et al., 1998) .
Dhont et al. compared their coasted patients with a historical cohort of patients who had been stimulated before 1993, when coasting wasn't used, but who had comparable E 2 levels. The authors also acknowledged that a long GnRH agonist scheme had been used for the control group, while a short scheme had been used in the coasted patients (Dhont et al., 1998) .
Lee et al. compared 20 coasted patients with 262 consecutive IVF patients who had no particular risk factors for OHSS (Lee et al., 1998) .
Ohata et al. compared ®ve coasted cycles with ®ve previous cycles of the same patients who had suffered severe OHSS (Ohata et al., 2000) .
Aboulghar et al. studied two different schemes of coasting: either they withdrew HMG (classical coasting, n = 24) or they decreased the HMG before stopping it (modi®ed coasting, n = 25) and compared these two groups with a third`historical' group of 32 patients at risk (Aboulghar et al., 2000) .
More recently, Al-Shawaf et al. conducted a prospective observational study. They compared coasted patients (follicles >20 and E 2 b3596 pg/ml) with a group of`modi®ed' coasted patients (>20 follicles and E 2 of 817±3596 pg/ml), a`maintenance group' (>20 follicles and E 2 <817 pg/ml) and a low-risk group of patients (Al-Shawaf et al., 2001) .
For the purpose of the further analysis we have considered only the`classical' coasting groups of patients in the two latter studies.
Results of coasting and IVF
The results of these different stimulation schemes in terms of E 2 level on the coasting day and on HCG administration day, the collected oocytes, fertilization and pregnancy rates are provided in Table II . The mean levels of peak serum E 2 that were reached varied between 4882 pg/ml (T183) for the study of Tortoriello et al. and 7650 (range 6270±12780) for Sher et al. (Sher et al., 1995; Tortoriello et al., 1998) . This disparity probably re¯ects the variation in the selected value of E 2 to start the coasting and different assay methods. Similarly, the number of oocytes collected also varies between studies, ranging from 9.2 to 21.
The fertilization rate varied between 36.7 and 71% and the implantation rate between 9.5 and 31%. Finally, the pregnancy rate varied between 20 and 63.6% and the abortion rate between 3.9 and 28% with a mean of 17.9%.
The mean duration of the coasting period was 3.6 days (range 1.6±5.3). The shortest coasting period was predictably seen in the study of Dhont et al. who also tolerated the lowest maximal E 2 , considering that Dechaud et al. cancelled cycles when the coasting period lasted for >4 days (Dhont et al., 1998; Dechaud et al., 2000) .
In ®ve studies, E 2 increased immediately after the coasting period was initiated (Sher et al., 1995; Lee et al., 1998; Egbase et al., 1999; Fluker et al., 1999; Waldenstro Èm et al., 1999) .This rise in E 2 lasted for 1±3 days after which a decrease in E 2 occurred. However, other investigators observed an immediate decrease of E 2 when gonadotrophins were withdrawn (Benadiva et al., 1997; Tortoriello et al., 1998) . Egbase, who studied the dynamics of E 2 , observed an increase in E 2 during the ®rst 24 h, which was followed by a daily decrease of 40% thereafter (Egbase, 2000) . Those who studied the evolution of the follicular diameter observed a follicular growth during the ®rst 36 h of the coasting period (Sher et al., 1995) .
It is impossible quantitatively to summarize the risk of developing mild, moderate or severe OHSS associated with coasting, because of the different classi®cations of OHSS that were used by the investigators: three studies used a classi®cation described by Schenker and Weinstein (Schenker and Weinstein, 1978) , four used Navot's (Navot et al., 1992) classi®cation, two Golan's (Golan et al., 1989) classi®cation, two used their own classi®cation and one study did not state precisely which classi®cation was used.
Thus, only a descriptive analysis can be provided. About 2% of patients for which the data were accessible (n = 3) required hospitalization. Ascites was either diagnosed by ultrasound or clinically de®ned as necessitating paracentesis, and it was found in 16.3% of cases (46/283). Haemoconcentration occurred in 2.8% of the patients (7/378) for which this information was available (Table III) .
Some studies compared the incidence of OHSS with that of a control group: Benadiva et al. found an incidence of 4.6% moderate OHSS in his population of coasted patients and 7.6% in a group of women for whom the embryos were cryopreserved (not statistically different) (Benadiva et al., 1997). Tortoriello et al. compared the group of coasted women with a group of women who reached similar E 2 levels at the time of HCG administration without coasting and also with a third group of women who responded`normally' to stimulation (Tortoriello et al., 1998) . In their experience there was no difference in the incidence of moderate and severe OHSS between the three groups of women. In a subgroup of 22 coasted women who reached E 2 levels >4000 pg/ml, three patients (13, 6%) developed a severe form of OHSS while none of the coasted women who reached lower E 2 levels did so. Furthermore, the only`critical' OHSS that occurred happened among the non-coasted women who had reached rather high E 2 levels.
Dhont et al. obtained a signi®cantly lower number of OHSS cases (moderate and severe) in coasted patients than in their control group (P < 0.01). Similarly, more patients were hospitalized within the group of women who were not coasted than within the group who were (Dhont et al., 1998) .
On the other hand, Lee et al. observed more severe OHSS cases (20%) within the coasted women than in the general reference population (1%), but these women presented no risk factors for OHSS (Lee et al., 1998) .
In the randomized study of Egbase et al. no signi®cant difference was observed among severe OHSS cases (20 versus 26.6%) between coasted patients (n = 15) and those who underwent a unilateral follicular aspiration (n = 15) (Egbase et al., 1999) .
Ohata et al. observed that no OHSS developed in ®ve women during a coasted cycle, while all had developed severe OHSS when they were not coasted during a previous cycle (Ohata et al., 2000) .
Aboulghar et al. observed an incidence of severe OHSS of 25% (eight cases out of 32) in a`historical' cohort of women with rather high E 2 levels (mean 7200 T 2150 pg/ml) as compared with 17% (four cases out of 24) in the coasted group (Aboulghar et al., 2000) .
Discussion
All investigators de®ned coasting as a preventive method that was performed by withdrawing the administration of gonadotrophins in patients who had reached a certain threshold value of serum E 2 and/or a critical number of follicles. Globally, a majority of the authors selected an E 2 value >2500±3000 pg/ml as the threshold limit with the presence of at least three mature follicles. It is possible that the number of mature follicles has no prognostic value since Lee et al. paradoxically only started to coast with fewer than three mature follicles and obtained comparable results with others (Lee et al., 1998) . In our previous survey, a majority of clinicians had also selected the value of 3000 pg/ml E 2 as the critical threshold value (Delvigne and Rozenberg, 2000) . The IVF results that were reported by the different coasting studies were comparable or even superior in terms of success rates than those reported by many large databanks for IVF such as the Society for Assisted Reproductive Technology (SART) and the French National Register on In vitro Fertilization (FIVNAT) (French National Register on In vitro Fertilization, 1996; Society for Assisted Reproductive Technology, 1999). For instance, the number of retrieved oocytes in the coasted studies (9.2±21) is higher than that of FIVNAT (8.4 T 5.7), suggesting that follicular atresia due to the coasting has little or no effect on the number of oocytes collected. On the other hand, Egbase et al. calculated the rate of oocytes retrieved in relation to the rate of follicles punctured and observed a signi®cantly lower rate (28.3 T 3.7%) compared with a control group (91.4 T 4.4%) (Egbase et al., 1999) . Dhont et al. observed that the number of oocytes retrieved was lower in the coasted group of patients than in their historical control group (Dhont et al., 1998) .
Unfortunately, no author has calculated the number of retrieved oocytes in relation to the number and size of visualized follicles. Such data may provide information on whether smaller or larger follicles evolve into atresia. For most studies, an acceptable ratio of retrieved oocytes by E 2 level at the retrieval time was found, ranging between 194 and 364 pg/ml. Only two studies (Fluker et al., 1999; Waldenstro Èm et al., 1999) found a lower oocyte ratio, corresponding to serum levels of 470 and 694 pg/ml E 2 per retrieved oocyte. We have no explanation for these ®ndings. However, one should note that in the study of Waldenstro Èm et al. the decrease of E 2 is the greatest of all of the studies, suggesting that this may affect the retrieval rate of oocytes (Waldenstro Èm et al., 1999) .
The fertilization rate varied between 36.7 and 71%, which is also comparable with that of FIVNAT (49.2%) (French National Register on In vitro Fertilization, 1996) . Likewise, the pregnancy rate of 20±63.6% and the miscarriage rate of 17.9% are acceptable in comparison with those of SART (respectively 26.2 and 16.6%) (Society for Assisted Reproductive Technology, 1999) It is impossible to draw conclusions about the optimal decrease in E 2 during the coasting period, and about its optimal duration. One can only observe that Benadiva et al. who cancelled the cycle when E 2 decreased by >20% (in ®ve patients out of 22) did not achieve superior results in terms of oocyte retrieval, fertilization and pregnancy rates (Benadiva et al., 1997) . Likewise, Aboulghar et al. who cancelled the cycle when E 2 decreased to a level <1500 pg/ml did not achieve superior results either (four patients out of 24) (Aboulghar et al., 2000) . Tortoriello et al. found a signi®cant relationship between the duration of coasting and the E 2 level that was reached (Tortoriello et al., 1998) (Dechaud et al., 2000) .
It is also impossible to synthesize the data of the different studies as a global and single result in terms of the risk of developing OHSS because of the wide heterogeneity of the study protocols, their diversity of control groups and even their varied de®nitions of OHSS classes. In order to quantify the true bene®t of coasting, a large randomized controlled study where protocols are standardized would be needed. , 1997 (22) NA NA 1 moderate OHSS/classi®cation non precised Tortoriello et al., 1998 (44) 6 (5 Clinically and 3 1 at ultrasound) Dhont et al., 1998 (120) NA 1 5.8% of moderate (involves ascites) and severe OHSS Lee et al., 1998 (20) 4 (2 paracentesis) NA 4 severe OHSS (distress with ovarian enlargement and ascites) Fluker et al., 1999 (63) 1 1 Cumulated results of 2 groups (classical and modi®ed coasting n = 93), 9/93 had nausea and vomiting, 2 had ascites Waldenstrom et al., 1999 (65) <300 ml: 6/61 2/61 1 paracentesis 300±800 ml: 3/61 >800 ml: 2/61 Egbase et al., 1999 (15) 3 NA 3 additional cases of moderate OHSS when considering the classi®cation of Schenker Dechaud et al., 2000 (14) NA 0/10 Refers only to severe forms of OHSS Ohata et al., 2000 (5) 5 0 Ascites at ultrasound Aboulghar et al., 2000 (24) 4 Still, in 16% of the cycles ascites was described, but this includes both moderate OHSS forms which were occasional ultrasound ®ndings, as well as clinical symptomatic ascites, necessitating paracentesis to relieve patients from respiratory symptoms. In~2.5% of the patients the OHSS required hospitalization, and 2.8% presented haemoconcentration abnormalities.
The reported incidence of 2.5% of severe forms of OHSS in coasted cycles is rather low in relation to their calculated mean E 2 level (5785 pg/ml for the 190 patients from which the maximum E 2 value was available). It is also low in relation to their calculated mean oocyte number of 15. Indeed, the reported risk of OHSS in`regular IVF' is much higher when elevated E 2 levels or high oocytes numbers are reached. According to Ash et al. 38% of patients with E 2 levels >6000 pg/ml develop a severe form of OHSS, whereas 23% develop it when >30 oocytes are retrieved and 80% when both conditions are encountered (Ash et al., 1991) . Morris et al. also observed that 20% of high-risk patients developed a severe form of OHSS after embryo transfer (Morris et al., 1995) . Coasting can thus be used to prevent OHSS, since it considerably decreases the OHSS incidence in these high-risk patients.
Nevertheless, coasting does not totally avoid the risk of OHSS and one should be aware of this. Furthermore, many questions remain unanswered about the way coasting should be managed and many contradictions are found in the published studies. It remains doubtful whether it is useful to obtain mature follicles before starting the coasting, and whether it is necessary to cancel cycles when E 2 levels decrease below a certain value or when the coasting period is too long. We think that it would be unethical to randomize women exposed to a very high risk, either to coasting or regular IVF. Nevertheless, it would be feasible to perform a prospective randomized trial where either cycle cancellation or cryopreservation is compared with coasting. Cryopreservation may be less effective in terms of implantation rate, but has the advantage of avoiding exposure to endogenous HCG. Because the incidence of OHSS is low, it is dif®cult to conduct such a study in a single centre and we feel that only a large, multicentre study would provide valuable information.
